In part 6, the conclusion of this Exclusive Interview, Nancy D'Hondt talks with Diabetes in Control Publisher Steve Freed about the daily effectiveness of online and in-person interaction with peers who also have diabetes.
Read More »Low Carb Or Low Fat Diet To Lose Weight?
Study provides some answers to ongoing debate about which diet causes most weight loss.
Read More »Sedentary Behavior During Pregnancy and Neonatal Adiposity
Lifestyle intervention in pregnancy might reduce adverse effects of maternal obesity on neonatal adiposity.
Read More »Statins And The Risk of Developing Diabetes
Recent studies have shown that statins can raise blood sugar and more patients on statin therapy were diagnosed with diabetes mellitus.
Read More »Fasting Glucose Estimates Absolute Risk for CVD
Monitoring glucose in midlife may help prevent future cardiovascular disease, according to a study published in Diabetes Care.
Read More »First Dual SGLT-1/2 Inhibitor For Adults With Type 1 Declined Approval
Sanofi and Lexicon to continue any required studies in effort to move sotagliflozin forward.
Read More »New FDA Extension for Farxiga and Xigduo XR
Dapagliflozin’s updated package insert confirms efficacy and safety profile for patients with moderate chronic kidney disease.
Read More »Paula Trief 2018 Complete Interview
Paula Trief, PhD received her PhD in Clinical Psychology from Syracuse University. She joined the faculty at SUNY Upstate Medical University in the Department of Psychiatry & Behavioral Sciences in 1993. She is currently a tenured Distinguished Service Professor of Psychiatry & Behavioral Sciences, with joint appointments in the departments of Medicine and Orthopedic Surgery. Academically, she is an active behavioral science researcher, studying behavioral interventions for patients with diabetes. Her current RO1 studies factors that predict medication adherence and healthcare usage in emerging adults with type 2 diabetes.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #170: Molecular Genetics of Type 1 Diabetes Part 7
Clinical utility of T1DM susceptibility genes: One of the goals of genetic studies of complex disease is to identify a profile of susceptibility variants that can be used to predict an individual’s risk of developing a given disease. The long prodrome for T1DM, characterized by progressive loss of beta-cell mass, provides an attractive opportunity for intervention to prevent disease development if “at-risk” individuals can be identified. Currently the best markers of disease risk are a positive family history of T1DM and the presence of autoantibodies to islet cell proteins. Over 90% of T1DM patients have no affected relatives, however, so effective preventive efforts will need to target the general population. Unfortunately screening such huge numbers of individuals for islet autoantibodies is logistically unfeasible, particularly given the need for repeated annual testing for those with a negative result. Genetic markers are therefore needed to stratify risk in the general population,
Read More »Paula Trief 2018 Transcript
In this Exclusive Interview transcript, psychologist Paula Trief talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about the role of mental health in diabetes and how partners of people with diabetes can be of support in diabetes care.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.